vs
AMREP CORP.（AXR）与IRIDEX CORP（IRIX）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是AMREP CORP.的1.0倍（$14.7M vs $14.6M），AMREP CORP.同比增速更快（93.8% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs -13.6%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
AXR vs IRIX — 直观对比
营收规模更大
IRIX
是对方的1.0倍
$14.6M
营收增速更快
AXR
高出163.5%
-69.7%
两年增速更快
IRIX
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $14.7M |
| 净利润 | $3.1M | — |
| 毛利率 | — | 37.2% |
| 营业利润率 | 20.6% | — |
| 净利率 | 21.6% | — |
| 营收同比 | 93.8% | -69.7% |
| 净利润同比 | 338.9% | — |
| 每股收益（稀释后） | $0.58 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRIRIX
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $14.7M | ||
| Q3 25 | $17.9M | $12.5M | ||
| Q2 25 | $11.2M | $13.6M | ||
| Q1 25 | $7.5M | $11.9M | ||
| Q4 24 | $11.9M | $12.7M | ||
| Q3 24 | $19.1M | $11.6M | ||
| Q2 24 | $19.5M | $12.6M |
净利润AXRIRIX
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | — | ||
| Q3 25 | $4.7M | $-1.6M | ||
| Q2 25 | $3.9M | $-994.0K | ||
| Q1 25 | $717.0K | $-1.7M | ||
| Q4 24 | $4.0M | $-834.0K | ||
| Q3 24 | $4.1M | $-1.9M | ||
| Q2 24 | $4.1M | $-2.7M |
毛利率AXRIRIX
| Q1 26 | — | — | ||
| Q4 25 | — | 37.2% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 34.5% | ||
| Q1 25 | — | 42.5% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 40.7% |
营业利润率AXRIRIX
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | — | ||
| Q3 25 | 34.4% | -11.3% | ||
| Q2 25 | 31.7% | -6.9% | ||
| Q1 25 | 5.7% | -1.7% | ||
| Q4 24 | 26.4% | -3.9% | ||
| Q3 24 | 26.1% | -16.1% | ||
| Q2 24 | 23.9% | -20.9% |
净利率AXRIRIX
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | — | ||
| Q3 25 | 26.3% | -12.6% | ||
| Q2 25 | 34.8% | -7.3% | ||
| Q1 25 | 9.5% | -14.2% | ||
| Q4 24 | 33.9% | -6.6% | ||
| Q3 24 | 21.3% | -16.7% | ||
| Q2 24 | 21.2% | -21.2% |
每股收益（稀释后）AXRIRIX
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.87 | $-0.09 | ||
| Q2 25 | $0.73 | $-0.06 | ||
| Q1 25 | $0.13 | $-0.10 | ||
| Q4 24 | $0.75 | $-0.05 | ||
| Q3 24 | $0.76 | $-0.12 | ||
| Q2 24 | $0.77 | $-0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $6.0M |
| 总债务越低越好 | $21.0K | — |
| 股东权益账面价值 | $139.4M | — |
| 总资产 | $143.9M | $29.2M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AXRIRIX
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $6.0M | ||
| Q3 25 | $48.9M | $5.6M | ||
| Q2 25 | $39.5M | $6.8M | ||
| Q1 25 | $36.9M | $7.2M | ||
| Q4 24 | $40.1M | $2.4M | ||
| Q3 24 | $40.4M | $3.9M | ||
| Q2 24 | $29.7M | $4.1M |
总债务AXRIRIX
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | $1.0M | ||
| Q3 24 | $34.0K | $1.4M | ||
| Q2 24 | $35.0K | — |
股东权益AXRIRIX
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | — | ||
| Q3 25 | $134.7M | $4.7M | ||
| Q2 25 | $130.0M | $6.1M | ||
| Q1 25 | $126.0M | $852.0K | ||
| Q4 24 | $125.1M | $2.1M | ||
| Q3 24 | $122.2M | $2.6M | ||
| Q2 24 | $118.0M | $4.2M |
总资产AXRIRIX
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $29.2M | ||
| Q3 25 | $140.7M | $28.4M | ||
| Q2 25 | $133.8M | $31.6M | ||
| Q1 25 | $128.9M | $34.2M | ||
| Q4 24 | $129.1M | $29.1M | ||
| Q3 24 | $127.0M | $30.2M | ||
| Q2 24 | $122.8M | $31.2M |
负债/权益比AXRIRIX
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | 0.48× | ||
| Q3 24 | 0.00× | 0.53× | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | — |
| 自由现金流经营现金流 - 资本支出 | $5.4M | — |
| 自由现金流率自由现金流/营收 | 37.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | $20.2M | — |
8季度趋势，按日历期对齐
经营现金流AXRIRIX
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | $-1.2M | ||
| Q2 25 | $10.2M | $-397.0K | ||
| Q1 25 | $-3.2M | $-1.1M | ||
| Q4 24 | $-182.0K | $-1.2M | ||
| Q3 24 | $10.7M | $-3.1M | ||
| Q2 24 | $10.7M | $-1.3M |
自由现金流AXRIRIX
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | $-1.2M | ||
| Q2 25 | $9.7M | $-410.0K | ||
| Q1 25 | $-3.3M | $-1.2M | ||
| Q4 24 | $-268.0K | $-1.2M | ||
| Q3 24 | $10.7M | $-3.1M | ||
| Q2 24 | $10.3M | — |
自由现金流率AXRIRIX
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | — | ||
| Q3 25 | 53.2% | -9.4% | ||
| Q2 25 | 86.4% | -3.0% | ||
| Q1 25 | -43.4% | -9.8% | ||
| Q4 24 | -2.3% | -9.8% | ||
| Q3 24 | 55.8% | -26.5% | ||
| Q2 24 | 52.5% | — |
资本支出强度AXRIRIX
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 5.2% | 0.1% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% |
现金转化率AXRIRIX
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
